At ViroGates, we believe in staying ahead of illness. We’re proud to have developed and commercialized the suPARnostic® product line that enables the measurement of the biomarker suPAR (soluble urokinase Plasminogen Activator Receptor). suPAR is a powerful indicator of immune activation and inflammation, offering deep insight into a person’s health and disease risk. Our mission is to empower healthcare professionals and individuals with real-time data to detect risks early, make smarter health decisions, and optimize treatments. Designed with long-term healthcare impact in mind, suPARnostic® products are seamlessly integrated by clinicians and laboratory technicians into existing workflows. Fully approved for all major clinical chemistry analyzers, they deliver rapid results in less than 20 minutes.
Looking for a particular ViroGates employee's phone or email?
The ViroGates annual revenue was $1 million in 2026.
Jakob Knudsen is the CEO of ViroGates.
8 people are employed at ViroGates.
The NAICS codes for ViroGates are [325413, 325, 32541, 3254, 32].
The SIC codes for ViroGates are [283, 28].